Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease. (Q47881666)

6 February 2018

title

Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease. (English)

1 reference

6 February 2018

chronic obstructive pulmonary disease

main subject

1 reference

Franco Laghi

1

1 reference

6 February 2018

W Edwin Langbein

2

1 reference

6 February 2018

Andreea Antonescu-Turcu

3

1 reference

6 February 2018

Amal Jubran

4

1 reference

6 February 2018

Christine Bammert

5

1 reference

6 February 2018

Martin J Tobin

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

10 December 2004

1 reference

6 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

6 February 2018

volume

171

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

598-605

1 reference

6 February 2018

Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Catabolic/anabolic balance and muscle wasting in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Disorders of the respiratory muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Androgens in men--uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

The testicular effects of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Is weaning failure caused by low-frequency fatigue of the diaphragm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Feasibility of high-intensity, interval-based respiratory muscle training in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

The effects of learning on the ventilatory responses to inspiratory threshold loading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Incremental threshold loading: a standard protocol and establishment of a reference range in naive normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Inspiratory muscle endurance in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Respiratory muscle performance in normal elderly subjects and patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Issues in testosterone replacement in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Reversal of COPD-associated weight loss using the anabolic agent oxandrolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Androgen treatment of male hypogonadism in older males

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Hypogonadism in elderly men--what to do until the evidence comes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

Activation of human respiratory muscles during different voluntary manoeuvres

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1643OC

10.1164/RCCM.200412-1643OC

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

15591465

1 reference

6 February 2018